GlassScriptPhysician profile
Kurt H Strom
NPI 1336395334
$1,536.24
in general payments reported to CMS, 2019-2025
22 companies · $172 in 2025
The $172 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $99.52 · 2020: $332 · 2021: $65.17 · 2022: $190 · 2023: $314 · 2024: $363 · 2025: $172.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $850.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $849.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $246.29 | 2022-2023 | Interstim |
| Agiliti Health, INC. | $183.21 | 2020 | |
| Intuitive Surgical, INC. | $173.89 | 2024 | |
| Bluewind Medical | $113.22 | 2024 | Revi |
| Ferring Pharmaceuticals INC. | $98.13 | 2020 | |
| Sumitomo Pharma America, INC. | $93.12 | 2023-2025 | Orgovyx, Gemtesa |
| Boston Scientific Corporation | $83.62 | 2021-2025 | Axonics |
| Axonics, INC. | $83.10 | 2022-2023 | Axonics, Bulkamid |
| Medtronic USA, INC. | $82.97 | 2019-2020 | |
| Astellas Pharma US INC | $70.40 | 2021-2024 | Myrbetriq |
| Dendreon Pharmaceuticals LLC | $34.76 | 2022 | |
| Janssen Biotech, INC. | $33.32 | 2019-2024 | Akeega, Balversa, Erleada |
| Myovant Sciences INC. | $30.84 | 2021-2022 | |
| Pfizer INC. | $30.22 | 2020-2023 | |
| Calyxo, INC. | $27.94 | 2025 | Cvac Aspiration System |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $27.54 | 2023 | Nanoknife |
| Novartis Pharmaceuticals Corporation | $26.59 | 2025 | |
| Laborie Medical Technologies Corp. | $25.47 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Merck Sharp & Dohme LLC | $21.00 | 2024 | Keytruda, Welireg |
| 180 Medical, INC. | $18.33 | 2019 | |
| Myriad Genetic Laboratories, INC. | $16.97 | 2024 | Myrisk |
| Travere Therapeutics, INC. | $15.31 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kurt Strom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.